Siddhartha Kumar, Kumar Sandeep, Rakesh Kumar & Antresh Kumar. (2023)
Antimicrobial effect of pimozide by targeting ROS‐mediated killing in
Staphylococcus aureus
. Biotechnology and Applied Biochemistry.
Crossref
Bruno Almeida Costa, Tarek H. Mouhieddine & Joshua Richter. (2022) What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma. Targeted Oncology 17:4, pages 383-405.
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
799
885
.
Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir & Gianluca Trifirò. (2020) Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Frontiers in Pharmacology 11.
Crossref
Ruili Huang, Hu Zhu, Paul Shinn, Deborah Ngan, Lin Ye, Ashish Thakur, Gurmit Grewal, Tongan Zhao, Noel Southall, Mathew D. Hall, Anton Simeonov & Christopher P. Austin. (2019) The NCATS Pharmaceutical Collection: a 10-year update. Drug Discovery Today 24:12, pages 2341-2349.
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
721
796
.
E. Koch & S. Plassmann. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
7
38
.
Anuradha Roy & Rathnam Chaguturu. 2017. Innovative Approaches in Drug Discovery. Innovative Approaches in Drug Discovery
65
88
.
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
675
747
.
Martha C. Valbuena, Sandra Muvdi & Henry W. Lim. (2014) Actinic Prurigo. Dermatologic Clinics 32:3, pages 335-344.
Crossref
Roba Talaat, Waheba El-Sayed, Hussein Agwa, Amira Gamal-Eldeen, Shaden Moawia & Magdy Zahran. (2014) Novel thalidomide analogs: Anti-angiogenic and apoptotic effects on Hep-G2 and MCF-7 cancer cell lines. Biomedicine & Aging Pathology 4:3, pages 179-189.
Crossref
Stephen J. Mayall & Anjan K. Banerjee. 2014. Therapeutic Risk Management of Medicines. Therapeutic Risk Management of Medicines
25
59
.
Min Shen, Yaqin Zhang, Nakhle Saba, Christopher P. Austin, Adrian Wiestner & Douglas S. Auld. (2013) Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs. PLoS ONE 8:9, pages e75252.
Crossref
Imran AliWaseem A Wani, Ashanul Haque & Kishwar Saleem. (2013) Glutamic acid and its derivatives: candidates for rational design of anticancer drugs. Future Medicinal Chemistry 5:8, pages 961-978.
Crossref
Ruili HuangNoel SouthallYuhong Wang, Adam Yasgar, Paul Shinn, Ajit Jadhav, Dac-Trung Nguyen & Christopher P. Austin. (2011) The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics. Science Translational Medicine 3:80.
Crossref
Eric E. Prommer, Robert Twycross, Mary Mihalyo & Andrew Wilcock. (2011) Thalidomide. Journal of Pain and Symptom Management 41:1, pages 140-145.
Crossref
Norman T. Ilowite & Ronald M. Laxer. 2011. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
71
126
.
James P. Riehl. 2010. Mirror‐Image Asymmetry. Mirror‐Image Asymmetry
111
146
.
Lars Gullestad, Jan Kristian Damås, Arne Yndestad & Pål Aukrust. 2007. Immune Dysfunction and Immunotherapy in Heart Disease. Immune Dysfunction and Immunotherapy in Heart Disease
97
108
.
Norio Shibata, Takeshi Yamamoto & Takeshi Toru. 2007. Bioactive Heterocycles II. Bioactive Heterocycles II
73
97
.
Xiao-feng Kang, Stephen Cheley, Xiyun Guan & Hagan Bayley. (2006) Stochastic Detection of Enantiomers. Journal of the American Chemical Society 128:33, pages 10684-10685.
Crossref
Jonathan L. Finlay & Stergios Zacharoulis. (2005) The Treatment of High Grade Gliomas and Diffuse Intrinsic Pontine Tumors of Childhood and Adolescence: A Historical – and Futuristic – Perspective. Journal of Neuro-Oncology 75:3, pages 253-266.
Crossref
Lars GullestadThor UelandJan G. FjeldEven HoltTorstein GundersenKjell BreivikMagne FøllingAnders HodtRita SkårdalJohn KjekshusArne AndreassenElin KjekshusRagnhild WergelandArne YndestadStig S. FrølandAnne Grete SembPål Aukrust. (2005) Effect of Thalidomide on Cardiac Remodeling in Chronic Heart Failure. Circulation 112:22, pages 3408-3414.
Crossref
Ronald M. Laxer. 2005. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
76
141
.
Gerhard Bringmann, Doris Feineis, Ralf God, Katja Maksimenka, Jörg Mühlbacher, Kim Messer, Miriam Münchbach, Klaus-Peter Gulden, Eva-Maria Peters & Karl Peters. (2004) Resolution and chiroptical properties of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) and related compounds: quantum chemical CD calculations and X-ray diffraction analysis. Tetrahedron 60:37, pages 8143-8151.
Crossref
Hikaru Takaya, Kazunori Yoshida, Katsuhiro Isozaki, Hiroki Terai & Shun‐Ichi Murahashi. (2003) Transition‐Metal‐Based Lewis Acid and Base Ambiphilic Catalysts of Iridium Hydride Complexes: Multicomponent Synthesis of Glutarimides. Angewandte Chemie International Edition 42:28, pages 3302-3304.
Crossref
Hikaru Takaya, Kazunori Yoshida, Katsuhiro Isozaki, Hiroki Terai & Shun‐Ichi Murahashi. (2003) Transition‐Metal‐Based Lewis Acid and Base Ambiphilic Catalysts of Iridium Hydride Complexes: Multicomponent Synthesis of Glutarimides. Angewandte Chemie 115:28, pages 3424-3426.
Crossref
M.F McCarty. (2003) A wholly nutritional ‘multifocal angiostatic therapy’ for control of disseminated cancer. Medical Hypotheses 61:1, pages 1-15.
Crossref
Josep Manel Casanova Seuma, Manel Baradad Brusau & Rosa María Martí Laborda. (2003) Talidomida, redescubrir un viejo fármaco. Piel 18:8, pages 446-458.
Crossref
Robert V. House. 2003. Biotechnology and Safety Assessment. Biotechnology and Safety Assessment
191
231
.
Lars Gullestad, Anne Grete Semb, Even Holt, Rita Skårdal, Thor Ueland, Arne Yndestad, Stig S. Frøland & Pål Aukrust. (2002) Effect of thalidomide in patients with chronic heart failure. American Heart Journal 144:5, pages 847-850.
Crossref
Sunanda Kane, Lee Jayson Stone & Eli Ehrenpreis. (2002) Thalidomide as “Salvage” Therapy for Patients With Delayed Hypersensitivity Response to Infliximab. Journal of Clinical Gastroenterology 35:2, pages 149-150.
Crossref